Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3753-3761, July 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gleave, M.
Right arrow Articles by Chung, L. W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gleave, M.
Right arrow Articles by Chung, L. W. K.

Acceleration of Human Prostate Cancer Growth in Vivo by Factors Produced by Prostate and Bone Fibroblasts1

Martin Gleave, Jer-Tsong Hsieh, Chuan Gao, Andrew C. von Eschenbach and Leland W. K. Chung2

Urology Research Laboratory, Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Prostate cancer, the most prevalent cancer affecting men, frequently metastasizes to the axial skeleton where it produces osteoblastic lesions with growth rates often exceeding that of the primary tumor. To evaluate the role of tumor cell-host stromal interaction and stromal specific growth factors (GFs) in prostate cancer growth and progression, we coinoculated athymic mice with human prostate cancer cells (LNCaP) and various nontumorigenic fibroblasts s.c. LNCaP tumor formation was most consistently induced by human bone (MS) fibroblasts (62%), followed by embryonic rat urogenital sinus mesenchymal (rUGM) cells (31%) and Noble rat prostatic fibroblasts (17%), but not by NIH-3T3, normal rat kidney, or human lung CCD16 fibroblasts. Carcinomas formed preferentially in male hosts, demonstrating in vivo androgen sensitivity. The human prostate component of these tumors was confirmed with immunohistochemical staining for prostate-specific antigen (PSA), Northern analysis for PSA expression, and Southern analysis for human repetitive Alu sequences. Elevations in serum PSA paralleled the histomorphological and biochemical findings.

LNCaP and fibroblast cell-conditioned media (CM) was used to determine whether autocrine and paracrine mitogenic pathways exist between LNCaP and fibroblast cells in vitro, and various defined GFs were tested to identify possible active factors. Mitogenic assays revealed a 200–300% bidirectional stimulation between LNCaP and bone or prostate fibroblast-derived CM. Lung, normal rat kidney, and 3T3 fibroblast CM were not mitogenic for LNCaP cells. Among the purified GFs tested basic fibroblast growth factor (bFGF) was the most potent mitogen, stimulating LNCaP growth 180% in a concentration-dependent manner. Transforming growth factor {alpha} and epidermal growth factor were both minimally mitogenic. Coinoculation of LNCaP cells with a slowly adsorbed matrix (Gelfoam) adsorbed with bFGF or dialyzed and concentrated rUGM or MS CM was also capable of inducing LNCaP tumor formation in vivo. These observations illustrate that fibroblasts differentially modulate prostate cancer growth through the release of paracrine-mediated GFs, possibly including bFGF, and that tumor-stromal cell interactions play an important role in prostate cancer growth and progression.

1 This work was supported in part by grant DK-38649 from the National Institutes of Health.

2 To whom requests for reprints should be addressed, University of Texas M. D. Anderson Cancer Center, Urology Research Laboratory, Box 026, 1515 Holcombe Blvd., Houston, TX 77030.

Received 1/22/91. Accepted 4/29/91.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton
Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction
Endocr. Rev., April 1, 2008; 29(2): 193 - 216.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev., March 1, 2008; 22(5): 559 - 574.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hara, H. Miyazaki, A. Lee, C. P. Tran, and R. E. Reiter
Androgen Receptor and Invasion in Prostate Cancer
Cancer Res., February 15, 2008; 68(4): 1128 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Li, Y.-H. Liu, S.-J. Lee, T. A. Gardner, M.-H. Jeng, and C. Kao
Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy
Clin. Cancer Res., January 1, 2008; 14(1): 291 - 299.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Li, Y.-H. Liu, Y.-P. Zhang, S. Zhang, X. Pu, T. A. Gardner, M.-H. Jeng, and C. Kao
Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy
Clin. Cancer Res., September 15, 2007; 13(18): 5463 - 5473.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-Q. Zhu, S. N. Popova, E. R. S. Brown, D. Barsyte-Lovejoy, R. Navab, W. Shih, M. Li, M. Lu, I. Jurisica, L. Z. Penn, et al.
Integrin {alpha}11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells
PNAS, July 10, 2007; 104(28): 11754 - 11759.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-H. Liu, A. Kirschenbaum, S. Yao, G. Liu, S. A. Aaronson, and A. C. Levine
Androgen-Induced Wnt Signaling in Preosteoblasts Promotes the Growth of MDA-PCa-2b Human Prostate Cancer Cells
Cancer Res., June 15, 2007; 67(12): 5747 - 5753.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. C. O'Connor, M. C. Farach-Carson, C. J. Schneider, and D. D. Carson
Coculture with Prostate Cancer Cells Alters Endoglin Expression and Attenuates Transforming Growth Factor-{beta} Signaling in Reactive Bone Marrow Stromal Cells
Mol. Cancer Res., June 1, 2007; 5(6): 585 - 603.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li
Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis
Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Nazareth, L. Broderick, M. R. Simpson-Abelson, R. J. Kelleher Jr., S. J. Yokota, and R. B. Bankert
Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells
J. Immunol., May 1, 2007; 178(9): 5552 - 5562.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. B. Wetherill, J. K. Hess-Wilson, C. E.S. Comstock, S. A. Shah, C. R. Buncher, L. Sallans, P. A. Limbach, S. Schwemberger, G. F. Babcock, and K. E. Knudsen
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
Mol. Cancer Ther., December 1, 2006; 5(12): 3181 - 3190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-Y. Sung, H. Kubo, K. Shigemura, R. S. Arnold, S. Logani, R. Wang, H. Konaka, M. Nakagawa, S. Mousses, M. Amin, et al.
Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9519 - 9526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-C. Huang, D. Wu, Z. Xie, H. E. Zhau, T. Nomura, M. Zayzafoon, J. Pohl, C.-L. Hsieh, M. N. Weitzmann, M. C. Farach-Carson, et al.
{beta}2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis.
Cancer Res., September 15, 2006; 66(18): 9108 - 9116.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-C. Pong, R. Roark, J.-Y. Ou, J. Fan, J. Stanfield, E. Frenkel, A. Sagalowsky, and J.-T. Hsieh
Mechanism of Increased Coxsackie and Adenovirus Receptor Gene Expression and Adenovirus Uptake by Phytoestrogen and Histone Deacetylase Inhibitor in Human Bladder Cancer Cells and the Potential Clinical Application.
Cancer Res., September 1, 2006; 66(17): 8822 - 8828.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X. Li, S. P. Raikwar, Y.-H. Liu, S.-J. Lee, Y.-P. Zhang, S. Zhang, L. Cheng, S.-D. Lee, B. E. Juliar, T. A. Gardner, et al.
Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.
Mol. Cancer Ther., March 1, 2006; 5(3): 676 - 684.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. S. Joesting, S. Perrin, B. Elenbaas, S. E. Fawell, J. S. Rubin, O. E. Franco, S. W. Hayward, G. R. Cunha, and P. C. Marker
Identification of SFRP1 as a Candidate Mediator of Stromal-to-Epithelial Signaling in Prostate Cancer
Cancer Res., November 15, 2005; 65(22): 10423 - 10430.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Kim, P. Yang, M. Suraokar, A. L. Sabichi, N. D. Llansa, G. Mendoza, V. Subbarayan, C. J. Logothetis, R. A. Newman, S. M. Lippman, et al.
Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase-Derived Products
Cancer Res., July 15, 2005; 65(14): 6189 - 6198.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. J.C. Eigl, S. E. Eggener, J. Baybik, S. Ettinger, K. N. Chi, C. Nelson, Z. Wang, and M. E. Gleave
Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4905 - 4911.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-C. Huang, Z. Xie, H. Konaka, J. Sodek, H. E. Zhau, and L. W.K. Chung
Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway
Cancer Res., March 15, 2005; 65(6): 2303 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Li, Y.-P. Zhang, H.-S. Kim, K.-H. Bae, K. M. Stantz, S.-J. Lee, C. Jung, J. A. Jimenez, T. A. Gardner, M.-H. Jeng, et al.
Gene Therapy for Prostate Cancer by Controlling Adenovirus E1a and E4 Gene Expression with PSES Enhancer
Cancer Res., March 1, 2005; 65(5): 1941 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sato, N. Maehara, and M. Goggins
Gene Expression Profiling of Tumor-Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts
Cancer Res., October 1, 2004; 64(19): 6950 - 6956.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N.-A. Pham, J. W. Jacobberger, A. D. Schimmer, P. Cao, M. Gronda, and D. W. Hedley
The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice
Mol. Cancer Ther., October 1, 2004; 3(10): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Aalinkeel, M. P. N. Nair, G. Sufrin, S. D. Mahajan, K. C. Chadha, R. P. Chawda, and S. A. Schwartz
Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
Cancer Res., August 1, 2004; 64(15): 5311 - 5321.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Fan, C. V. Pepicelli, C. C. Dibble, W. Catbagan, J. L. Zarycki, R. Laciak, J. Gipp, A. Shaw, M. L. G. Lamm, A. Munoz, et al.
Hedgehog Signaling Promotes Prostate Xenograft Tumor Growth
Endocrinology, August 1, 2004; 145(8): 3961 - 3970.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Shirakawa, K. Hamada, Z. Zhang, H. Okada, M. Tagawa, S. Kamidono, M. Kawabata, and A. Gotoh
A Cox-2 Promoter-Based Replication-Selective Adenoviral Vector to Target the Cox-2-Expressing Human Bladder Cancer Cells
Clin. Cancer Res., July 1, 2004; 10(13): 4342 - 4348.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Ueno, A M Jones, K H Wilkinson, J R Jass, and I C Talbot
Histological categorisation of fibrotic cancer stroma in advanced rectal cancer
Gut, April 1, 2004; 53(4): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Ettinger, R. Sobel, T. G. Whitmore, M. Akbari, D. R. Bradley, M. E. Gleave, and C. C. Nelson
Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence
Cancer Res., March 15, 2004; 64(6): 2212 - 2221.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Blaszczyk, B. A. Masri, N. R. Mawji, T. Ueda, G. McAlinden, C. P. Duncan, N. Bruchovsky, H.-U. Schweikert, D. Schnabel, E. C. Jones, et al.
Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells
Clin. Cancer Res., March 1, 2004; 10(5): 1860 - 1869.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hara, K. Nakamura, H. Araki, M. Kusaka, and M. Yamaoka
Enhanced Androgen Receptor Signaling Correlates with the Androgen-refractory Growth in a Newly Established MDA PCa 2b-hr Human Prostate Cancer Cell Subline
Cancer Res., September 1, 2003; 63(17): 5622 - 5628.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kiyama, K. Morrison, T. Zellweger, M. Akbari, M. Cox, D. Yu, H. Miyake, and M. E. Gleave
Castration-Induced Increases in Insulin-Like Growth Factor-Binding Protein 2 Promotes Proliferation of Androgen-independent Human Prostate LNCaP Tumors
Cancer Res., July 1, 2003; 63(13): 3575 - 3584.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. H. Ngo, R. J. Barnard, P. Cohen, S. Freedland, C. Tran, F. deGregorio, Y. I. Elshimali, D. Heber, and W. J. Aronson
Effect of Isocaloric Low-fat Diet on Human LAPC-4 Prostate Cancer Xenografts in Severe Combined Immunodeficient Mice and the Insulin-like Growth Factor Axis
Clin. Cancer Res., July 1, 2003; 9(7): 2734 - 2743.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Chauhan, A Abraham, J R A Phillips, J H Pringle, R A Walker, and J L Jones
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions
J. Clin. Pathol., April 1, 2003; 56(4): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. C. Polek, L. V. Stewart, E. J. Ryu, M. B. Cohen, E. A. Allegretto, and N. L. Weigel
p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells
Endocrinology, January 1, 2003; 144(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-L. Hsieh, L. Yang, L. Miao, F. Yeung, C. Kao, H. Yang, H. E. Zhau, and L. W. K. Chung
A Novel Targeting Modality to Enhance Adenoviral Replication by Vitamin D3 in Androgen-independent Human Prostate Cancer Cells and Tumors
Cancer Res., June 1, 2002; 62(11): 3084 - 3092.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Tuxhorn, S. J. McAlhany, T. D. Dang, G. E. Ayala, and D. R. Rowley
Stromal Cells Promote Angiogenesis and Growth of Human Prostate Tumors in a Differential Reactive Stroma (DRS) Xenograft Model
Cancer Res., June 1, 2002; 62(11): 3298 - 3307.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Karan, B. M. Schmied, B. J. Dave, U. A. Wittel, M.-F. Lin, and S. K. Batra
Decreased Androgen-responsive Growth of Human Prostate Cancer Is Associated with Increased Genetic Alterations
Clin. Cancer Res., November 1, 2001; 7(11): 3472 - 3480.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Cinar, K. S. Koeneman, M. Edlund, G. S. Prins, H. E. Zhau, and L. W. K. Chung
Androgen Receptor Mediates the Reduced Tumor Growth, Enhanced Androgen Responsiveness, and Selected Target Gene Transactivation in a Human Prostate Cancer Cell Line
Cancer Res., October 1, 2001; 61(19): 7310 - 7317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Okegawa, R.-C. Pong, Y. Li, J. M. Bergelson, A. I. Sagalowsky, and J.-T. Hsieh
The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure
Cancer Res., September 1, 2001; 61(17): 6592 - 6600.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Spitzweg, M. K. O’Connor, E. R. Bergert, D. J. Tindall, C. Y. F. Young, and J. C. Morris
Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter
Cancer Res., November 1, 2000; 60(22): 6526 - 6530.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
D. Cowen, N. Salem, F. Ashoori, R. Meyn, M. L. Meistrich, J. A. Roth, and A. Pollack
Prostate Cancer Radiosensitization in Vivo with Adenovirus-mediated p53 Gene Therapy
Clin. Cancer Res., November 1, 2000; 6(11): 4402 - 4408.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Okegawa, Y. Li, R.-C. Pong, J. M. Bergelson, J. Zhou, and J.-T. Hsieh
The Dual Impact of Coxsackie and Adenovirus Receptor Expression on Human Prostate Cancer Gene Therapy
Cancer Res., September 1, 2000; 60(18): 5031 - 5036.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
K.-i. Nakashiro, M. Okamoto, Y. Hayashi, and R. Oyasu
Hepatocyte Growth Factor Secreted by Prostate-Derived Stromal Cells Stimulates Growth of Androgen-Independent Human Prostatic Carcinoma Cells
Am. J. Pathol., September 1, 2000; 157(3): 795 - 803.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. K. Jackson, M. E. Gleave, V. Yago, E. Beraldi, W. L. Hunter, and H. M. Burt
The Suppression of Human Prostate Tumor Growth in Mice by the Intratumoral Injection of a Slow-Release Polymeric Paste Formulation of Paclitaxel
Cancer Res., August 1, 2000; 60(15): 4146 - 4151.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Miyake, C. Nelson, P. S. Rennie, and M. E. Gleave
Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3'-Kinase Pathway
Endocrinology, June 1, 2000; 141(6): 2257 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Miyake, M. Pollak, and M. E. Gleave
Castration-induced Up-Regulation of Insulin-like Growth Factor Binding Protein-5 Potentiates Insulin-like Growth Factor-I Activity and Accelerates Progression to Androgen Independence in Prostate Cancer Models
Cancer Res., June 1, 2000; 60(11): 3058 - 3064.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Miyake, C. Nelson, P. S. Rennie, and M. E. Gleave
Acquisition of Chemoresistant Phenotype by Overexpression of the Antiapoptotic Gene Testosterone-repressed Prostate Message-2 in Prostate Cancer Xenograft Models
Cancer Res., May 1, 2000; 60(9): 2547 - 2554.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
H. Miyake, K. N. Chi, and M. E. Gleave
Antisense TRPM-2 Oligodeoxynucleotides Chemosensitize Human Androgen-independent PC-3 Prostate Cancer Cells Both in Vitro and in Vivo
Clin. Cancer Res., May 1, 2000; 6(5): 1655 - 1663.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Miyake, C. Nelson, P. S. Rennie, and M. E. Gleave
Testosterone-repressed Prostate Message-2 Is an Antiapoptotic Gene Involved in Progression to Androgen Independence in Prostate Cancer
Cancer Res., January 1, 2000; 60(1): 170 - 176.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. M. Adam, J. G. Borer, B. J. Williams, J. A. Eastham, K. R. Loughlin, and M. R. Freeman
Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate
Endocrinology, December 1, 1999; 140(12): 5866 - 5875.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. M. Dougherty, E. A. G. Blomme, A. J. Koh, J. E. Henderson, K. J. Pienta, T. J. Rosol, and L. K. McCauley
Parathyroid Hormone-related Protein as a Growth Regulator of Prostate Carcinoma
Cancer Res., December 1, 1999; 59(23): 6015 - 6022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Chott, Z. Sun, D. Morganstern, J. Pan, T. Li, M. Susani, I. Mosberger, M. P. Upton, G. J. Bubley, and S. P. Balk
Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor
Am. J. Pathol., October 1, 1999; 155(4): 1271 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Miyake, I. Hara, K. Gohji, K. Yamanaka, S. Hara, S. Arakawa, M. Nakajima, and S. Kamidono
Relative Expression of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in Mouse Renal Cell Carcinoma Cells Regulates Their Metastatic Potential
Clin. Cancer Res., October 1, 1999; 5(10): 2824 - 2829.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Gleave, A. Tolcher, H. Miyake, C. Nelson, B. Brown, E. Beraldi, and J. Goldie
Progression to Androgen Independence Is Delayed by Adjuvant Treatment with Antisense Bcl-2 Oligodeoxynucleotides after Castration in the LNCaP Prostate Tumor Model
Clin. Cancer Res., October 1, 1999; 5(10): 2891 - 2898.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Miyake, A. Tolcher, and M. E. Gleave
Antisense Bcl-2 Oligodeoxynucleotides Inhibit Progression to Androgen-Independence after Castration in the Shionogi Tumor Model
Cancer Res., August 1, 1999; 59(16): 4030 - 4034.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. N. Thalmann, R. A. Sikes, R. E. Devoll, J. A. Kiefer, R. Markwalder, I. Klima, C. M. Farach-Carson, U. E. Studer, and L. W. K. Chung
Osteopontin: Possible Role in Prostate Cancer Progression
Clin. Cancer Res., August 1, 1999; 5(8): 2271 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Nemeth, J. F. Harb, U. Barroso Jr., Z. He, D. J. Grignon, and M. L. Cher
Severe Combined Immunodeficient-hu Model of Human Prostate Cancer Metastasis to Human Bone
Cancer Res., April 1, 1999; 59(8): 1987 - 1993.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Putz, Z. Culig, I. E. Eder, C. Nessler-Menardi, G. Bartsch, H. Grunicke, F. Uberall, and H. Klocker
Epidermal Growth Factor (EGF) Receptor Blockade Inhibits the Action of EGF, Insulin-like Growth Factor I, and a Protein Kinase A Activator on the Mitogen-activated Protein Kinase Pathway in Prostate Cancer Cell Lines
Cancer Res., January 1, 1999; 59(1): 227 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Chen, S.-H. Lin, L. W. K. Chung, and R. A. Sikes
Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS
J. Biol. Chem., July 10, 1998; 273(28): 17618 - 17625.
[Abstract] [Full Text] [PDF]